Literature DB >> 9771253

X linked lymphoproliferative disease in a United Kingdom family.

P D Arkwright1, G Makin, A M Will, M Ayres, D A Gokhale, W D Fergusson, G M Taylor.   

Abstract

X linked lymphoproliferative disease (XLP; Duncan's disease) is a rare disorder affecting boys and characterised by a defective immune response to Epstein-Barr virus caused by a mutation in a gene located at chromosome Xq25. Three siblings with XLP in a single UK family are reported and the variation in phenotypic expression of the disease in these siblings described. One of the siblings with life threatening fulminant infectious mononucleosis was successfully treated by chemotherapy, followed by bone marrow transplantation using an unaffected brother as the donor. A healthy baby boy recently born into the family was identified as carrying the defective maternal X chromosome using molecular genetic linkage analysis. This family illustrates the extent of present understanding of this often fatal condition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771253      PMCID: PMC1717619          DOI: 10.1136/adc.79.1.52

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

2.  HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

Authors:  J I Henter; M Aricò; R M Egeler; G Elinder; B E Favara; A H Filipovich; H Gadner; S Imashuku; G Janka-Schaub; D Komp; S Ladisch; D Webb
Journal:  Med Pediatr Oncol       Date:  1997-05

3.  A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.

Authors:  I Ando; G Morgan; R J Levinsky; D H Crawford
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

4.  Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).

Authors:  H L Grierson; J Skare; J Church; T Silberman; J R Davis; N Kobrinsky; R McGregor; S Israels; J McCarty; L G Andrews
Journal:  Am J Med Genet       Date:  1993-09-15

Review 5.  X-linked lymphoproliferative disease.

Authors:  T A Seemayer; H Grierson; S J Pirruccello; T G Gross; D D Weisenburger; J Davis; K Spiegel; B Brichacek; J Sumegi
Journal:  Am J Dis Child       Date:  1993-11

6.  Construction of a human X-chromosome-enriched phage library which facilitates analysis of specific loci.

Authors:  L M Kunkel; M Lalande; A P Monaco; A Flint; W Middlesworth; S A Latt
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

8.  Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.

Authors:  D T Purtilo; K Sakamoto; V Barnabei; J Seeley; T Bechtold; G Rogers; J Yetz; S Harada
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

9.  Two anonymous X-specific human sequences detecting restriction fragment length polymorphisms in region Xq26----qter.

Authors:  B A Boggs; R L Nussbaum
Journal:  Somat Cell Mol Genet       Date:  1984-11

10.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more
  2 in total

Review 1.  X-linked lymphoproliferative syndrome.

Authors:  D L Nelson; C Terhorst
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.